eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in treating patients with invasive RxPONDER breast cancer

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
    Tamoxifen citrate
  3. Intervention
  4. Intervention
    Systemic chemotherapy
  5. Intervention
  6. Intervention
  7. Resource Description
    This phase III clinical trial is studying how well giving tamoxifen citrate, anastrozole, letrozole, or exemestane with or without chemotherapy works in treating patients with invasive breast cancer.
  8. Additional Name
    Phase III, randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients with 1-3 positive nodes, hormone receptor-positive and HER2-negative breast cancer with recurrence score (RS) of 25 or less
  9. Contact
    Berenberg, Jeffrey
  10. PI
    Berenberg, Jeffrey
  11. Topic
    breast cancer
  12. Study Population
    Females age 18 and older with histologically confirmed invasive breast cancer meeting criteria detailed on ClinicalTrials.gov.
  13. Website(s)
  14. Funded by
  15. Phase
    Phase 3 clinical trial
  16. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016